Creative Medical Technology Holdings Inc (CELZ)

[Lottoplay]

Type 1 AND 2!!!! “The positive one-year data from our Type 2 diabetes study is very encouraging, and we are excited to engage with clinicians in further translation," said Timothy Warbington, President and CEO of the Company. "Creative Medical Technology Holdings has a unique portfolio with multiple cell-based approaches that can potentially help patients with early-stage Type 1 Diabetes - CELZ-201, Brittle Type 1 Diabetes - CELZ-101, and late-stage Type 2 Diabetes - CELZ-001." https://www.otcmarkets.com/stock/CELZ/news/story?e&id=2495976